Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 2353  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Articlesmenu-bullet Search Instructions Online Submission Subscribe Etcetera Contact
 :: Next article
 :: Previous article 
 :: Table of Contents
 ::  Similar in PUBMED
 ::  Search Pubmed for
 ::  Search in Google Scholar for
 ::  Article in PDF (31 KB)
 ::  Citation Manager
 ::  Access Statistics
 ::  Reader Comments
 ::  Email Alert *
 ::  Add to My List *
* Registration required (free) 

  IN THIS Article
 ::  References

 Article Access Statistics
    PDF Downloaded104    
    Comments [Add]    
    Cited by others 4    

Recommend this journal


Year : 2009  |  Volume : 55  |  Issue : 3  |  Page : 231

Treatment options for ophthalmoplegic migraine

Department of Pediatrics, Hospital 12 de Octubre, Madrid, España

Date of Web Publication2-Nov-2009

Correspondence Address:
LIG Granado
Department of Pediatrics, Hospital 12 de Octubre, Madrid, España

Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0022-3859.57389

Rights and Permissions

How to cite this article:
Granado L, Guillen G. Treatment options for ophthalmoplegic migraine. J Postgrad Med 2009;55:231

How to cite this URL:
Granado L, Guillen G. Treatment options for ophthalmoplegic migraine. J Postgrad Med [serial online] 2009 [cited 2023 May 29];55:231. Available from:


The article by Borade et al.[1] provides an excellent description of the clinical picture shown, but regarding short-term and long-term management I would like to present two therapeutic options that were missed in their article, especially when prolonged ophthalmoplegia occurs.

We have to emphasize that ophthalmoplegic migraine is a diagnosis of exclusion, and noninvasive imaging tests such as magnetic resonance angiography (MRA) or magnetic resonance imaging (MRI) should be performed in all cases, to exclude the presence of one aneurysm. Usually ophthalmoplegia is a transient phenomenon. However, it can become permanent, especially after repeated attacks. In this case there are some concerns that longstanding lack of binocularity impedes the recovery of the alignment. For this reason, we can consider botulinum toxin A or surgical realignment (squint surgery) for short- or long-term management, respectively. The injection of botulinum toxin is safe (even for infants) [2] and painless, with appropriate topical analgesia, driven optionally with electromyography (we have been using botulinum toxin for the last four years without moderate or severe adverse effects, so - from our point of view - electromyography would be optional). As it is known, paralysis usually peaks two weeks after the injection. Because of the molecular turnover within the neuromuscular junction and neuronal sprouting, neuronal activity begins to return at three months, with restoration of complete function at approximately six months, so it can provide a longlasting, beneficial effect. It is not only safe and painless, even pain relief could be obtained with this strategy, as it has been proven previously. [3],[4],[5]

Botulinum toxin has previously been shown to produce longlasting recovery of binocular function in some patients with longstanding deviation. [6]

Even though large cohorts of patients are difficult to obtain in such infrequent diseases, we believe that worldwide observational studies could be helpful when deciding if a longlasting therapeutic strategy is needed (and which one) in these patients.

 :: References Top

1.Borade A, Prabhu AS, Kumar S, Prasad V, Rajam L. Magnetic resonance imaging findings in ophthalmoplegic migraine. J Postgrad Med 2009;55:137-8.  Back to cited text no. 1  [PUBMED]  Medknow Journal  
2.Pascual-Pascual SI, Pascual-Castroviejo I. Safety of botulinum toxin type A in children younger than 2 years. Eur J Paediatr Neurol Nov 2008. doi:10.1016/j.ejpn.2008.10.006 PMID: 1903661   Back to cited text no. 2 Sèze MP, de Sèze M, Dehail P, Joseph PA, Lavignolle B, Barat M, et al. Botulinum toxin A and musculoskeletal pain. Ann Readapt Med Phys 2003;46:329-32.  Back to cited text no. 3      
4.Gajraj NM. Botulinum toxin a injection of the obturator internus muscle for chronic perineal pain. J Pain 2005;6:333-7.  Back to cited text no. 4      
5.Colhado OC, Boeing M, Ortega LB. Botulinum toxin in pain treatment. Rev Bras Anestesiol 2009;59:366-81.  Back to cited text no. 5      
6.Manzouri B, Sainani A, Plant G, Lee J, Sloper J. The aetiology and management of long-lasting sixth nerve palsy in ophthalmoplegic migraine. Cephalalgia 2007;27:275-8.  Back to cited text no. 6      

This article has been cited by
1 Recurrent Painful Ophthalmoplegic Neuropathy: A case report with atypical features and a review of the literature
Alessandro Furia, Rocco Liguori, Vincenzo Donadio
Cephalalgia. 2023; 43(1): 0333102422
[Pubmed] | [DOI]
2 Ophthalmoplegic migraine with persistent dilated pupil
Sobreira, I. and Sousa, C. and Raposo, A. and Fagundes, F. and Dias, A.I.
Journal of Child Neurology. 2013; 28(2): 275-276
3 Ophthalmoplegic "migraine" or recurrent ophthalmoplegic cranial neuropathy: New cases and a systematic review
Gelfand, A.A. and Gelfand, J.M. and Prabakhar, P. and Goadsby, P.J.
Journal of Child Neurology. 2012; 27(6): 759-766
4 Authors′ reply
Borade, A. and Prabhu, A.S.
Journal of Postgraduate Medicine. 2009; 55(3): 231-232


Print this article  Email this article
Previous article Next article
Online since 12th February '04
© 2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow